[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Alhenc-Gelas et al., 1982 - Google Patents

Stimulation of prostaglandin formation by vasoactive mediators in cultured human endothelial cells

Alhenc-Gelas et al., 1982

Document ID
7052770715444852641
Author
Alhenc-Gelas F
Tsai S
Callahan K
Campbell W
Johnson A
Publication year
Publication venue
Prostaglandins

External Links

Snippet

Human endothelial cells in culture synthesize prostaglandins and release these products into the culture medium. The major products of arachidonic acid metabolism were identified by high pressure liquid chromatography or thin layer chromatography, and release of …
Continue reading at www.sciencedirect.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Similar Documents

Publication Publication Date Title
Alhenc-Gelas et al. Stimulation of prostaglandin formation by vasoactive mediators in cultured human endothelial cells
Busse et al. The role of endothelium in the control of vascular tone
Gryglewski et al. Bioassay of prostacyclin and endothelium-derived relaxing factor (EDRF) from porcine aortic endothelial cells.
Crutchley et al. Bradykinin-induced release of prostacyclin and thromboxanes from bovine pulmonary artery endothelial cells studies with lower homologs and calcium antagonists
Needleman et al. Cardiac and renal prostaglandin I 2: biosynthesis and biological effects in isolated perfused rabbit tissues
Whitaker et al. Triene prostaglandins: prostaglandin D3 and icosapentaenoic acid as potential antithrombotic substances
Rozengurt et al. Protein kinase C activation enhances cAMP accumulation in Swiss 3T3 cells: inhibition by pertussis toxin.
Hsueh et al. Hormone selective lipase activation in the isolated rabbit heart
LaMorte et al. Gallbladder prostaglandins and lysophospholipids as mediators of mucin secretion during cholelithiasis
Dembinska-Kiec et al. The generation of prostacyclin by arteries and by the coronary vascular bed is reduced in experimental atherosclerosis in rabbits
Camussi et al. The release of platelet-activating factor from human endothelial cells in culture.
Newman et al. Uptake and release of cholesterol by rabbit atheromatous lesions
Ali et al. Prostaglandin and thromboxane production by fibroblasts and vascular endothelial cells
Crowshaw The incorporation of [1-14C] arachidonic acid into the lipids of rabbit renal slices and conversion to prostaglandins E2 and F2α
Ludwig et al. Modulation of platelet-activating factor (PAF) synthesis and release from human polymorphonuclear leukocytes (PMN): role of extracellular albumin
Vadas et al. The release of phospholipase A2 from aggregated platelets and stimulated macrophages of sheep
Zucker et al. Tolerance development to antimitogenic actions of prostacyclin but not of prostaglandin E1 in coronary artery smooth muscle cells
Pfannkuche et al. A possible role of protein kinase C in regulating prostaglandin synthesis of mouse peritoneal macrophages
Wennmalm Prostaglandin-mediated inhibition of noradrenaline release: III. Separation of prostaglandins released from stimulated hearts and analysis of their neurosecretion inhibitory capacity
Ohuchi et al. Tumor promoting phorbol diesters stimulate release of radioactivity from [3H]-arachidonic acid labeled-but not [14C] linoleic acid labeled-cells. Indomethacin inhibits the stimulated release from [3H] arachidonate labeled cells
Roux et al. Lipid synthesis by rat brain microvessel endothelial cells in tissue culture
Stein et al. Metabolism of lysolecithin by the perfused rat heart
Moura et al. Cyclic AMP levels in cultured myocardial cells under the influence of chronotropic and inotropic agents
OTSUJI et al. Highly purified eicosapentaenoic acid attenuates tissue damage in experimental myocardial infarction
Pandol et al. Dual pathways for agonist-stimulated arachidonic acid release in pancreatic acini: roles in secretion